相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Treatment of psoriasis with non-registered fumaric acid esters in The Netherlands: a nationwide survey among Dutch dermatologists
S. Fallah Arani et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2014)
Predominance of activated, clonally expanded T helper type 17 cells within the CD4+T cell population in psoriatic lesions
B. J. Lewis et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Targeting IL-17 in psoriasis: From cutaneous immunobiology to clinical application
Maria-Eugenia Ariza et al.
CLINICAL IMMUNOLOGY (2013)
Th17 Cells Carrying TCR Recognizing Epidermal Autoantigen Induce Psoriasis-like Skin Inflammation
Shuhei Nishimoto et al.
JOURNAL OF IMMUNOLOGY (2013)
GM-CSF as a therapeutic target in inflammatory diseases
Annemarie van Nieuwenhuijze et al.
MOLECULAR IMMUNOLOGY (2013)
Th17 and Th22 cells in psoriatic arthritis and psoriasis
Helen Benham et al.
ARTHRITIS RESEARCH & THERAPY (2013)
New insights of T cells in the pathogenesis of psoriasis
Yihua Cai et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2012)
The roles of cells and cytokines in the pathogenesis of psoriasis
Susana Coimbra et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2012)
Effective and sustainable biologic treatment of psoriasis: what can we learn from new clinical data?
R. G. Langley
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2012)
Fumarates Promote Cytoprotection of Central Nervous System Cells against Oxidative Stress via the Nuclear Factor (Erythroid-Derived 2)-Like 2 Pathway
Robert H. Scannevin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Cytokine Secretion Pattern in Treatment of Lymphocytes of Multiple Sclerosis Patients with Fumaric Acid Esters
Samaneh Zoghi et al.
IMMUNOLOGICAL INVESTIGATIONS (2011)
Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells
Kamran Ghoreschi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
GM-CSF: the secret weapon in the TH17 arsenal
Mandy J. McGeachy
NATURE IMMUNOLOGY (2011)
RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation
Laura Codarri et al.
NATURE IMMUNOLOGY (2011)
The encephalitogenicity of TH17 cells is dependent on IL-1-and IL-23-induced production of the cytokine GM-CSF
Mohamed El-Behi et al.
NATURE IMMUNOLOGY (2011)
Circulating Th17, Th22, and Th1 Cells Are Increased in Psoriasis
Shinji Kagami et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis
Erin G. Harper et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis
Antonella Di Cesare et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Type 17 T helper cells-origins, features and possible roles in rheumatic disease
Francesco Annunziato et al.
NATURE REVIEWS RHEUMATOLOGY (2009)
Induction of IL-17+ T cell trafficking and development by IFN-γ:: Mechanism and pathological relevance in psoriasis
Ilona Kryczek et al.
JOURNAL OF IMMUNOLOGY (2008)
Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells
Michelle A. Lowes et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Immunopathogenesis of psoriasis
Robert Sabat et al.
EXPERIMENTAL DERMATOLOGY (2007)
Risk of myocardial infarction in patients with psoriasis
Joel M. Gelfand et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Advances in the management of psoriasis: monoclonal antibody therapies
D Mehrabi et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2002)
Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A
WI Al-Daraji et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)